NEUROPROTECTIVE EFFECT OF EMBELIN IN EXPERIMENTAL MODELS OF ALZHEIMER’S DISEASE

@inproceedings{Pillai2019NEUROPROTECTIVEEO,
  title={NEUROPROTECTIVE EFFECT OF EMBELIN IN EXPERIMENTAL MODELS OF ALZHEIMER’S DISEASE},
  author={B. Pillai},
  year={2019}
}
This PhD dissertation dealt with the evaluation of the neuroprotective effect of embelin in Alzheimer’s disease using experimental models. Embelin significantly improved memory functions in rats when assessed using various behavioral paradigms. Based on the behavioral, gene expression and protein analysis, it was found that embelin exerts its beneficial effect via cholinergic, amyloid and vascular pathway in Alzheimer’s like condition. Therefore, embelin could be a potential molecule for the… Expand

References

SHOWING 1-10 OF 107 REFERENCES
Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats.
TLDR
Embelin caused a significant reversal of behavioral and antioxidant status alterations and reversed the striatal neuronal damage induced by 3-NP, suggesting the neuroprotective effect of embelin against HD. Expand
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
TLDR
The therapeutic strategies that have been tested until now on the STZ-icv animal model have been reviewed and the comparability of the drugs’ efficacy in this non-transgenic sAD model and the results from clinical trials on sAD patients, evaluated. Expand
Advances in the Treatment of Alzheimer’s Disease: Benefits of Dual Cholinesterase Inhibition
TLDR
It is a priority for future clinical trials to determine whether agents with dual inhibition properties have greater clinical efficacy, and Rivastigmine is a dual inhibitor that has demonstrated benefits across the spectrum of AD severity and across the cognitive, functional and behavioural domains of AD. Expand
Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism
TLDR
Alzheimer's disease is the most common form of dementia which is characterized by severe neurodegenerative changes such as loss of neurons and synapses in brain. Expand
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
TLDR
Preclinical data have shown how these drugs act via two different, but interconnected, pathological pathways, and that their complementary activity may produce greater effects than either drug individually. Expand
Embelin Attenuates Intracerebroventricular Streptozotocin-Induced Behavioral, Biochemical, and Neurochemical Abnormalities in Rats
TLDR
Embelin dose dependently attenuated STZ-induced cognitive deficit and biochemical alterations and restored hippocampal neurochemical levels and suggest therapeutic potential of embelin in cognitive disorders such as sporadic Alzheimer’s disease (SAD). Expand
Effect of Embelin Against Lipopolysaccharide‐induced Sickness Behaviour in Mice
TLDR
Pre‐treatment with embelin attenuated behavioural changes induced by LPS, and prevented anhedonia, anorexia and ameliorated brain oxidative stress markers in mice, demonstrated protective effect of embelin in LPS‐induced sickness behaviour in mice. Expand
Multi-Target Screening and Experimental Validation of Natural Products from Selaginella Plants against Alzheimer's Disease
TLDR
A new strategy to improve the efficiency of active ingredients screening based on trace amount of natural product and numbers of targets is explored and some multi-target compounds with biological activity for the development of novel drugs for AD treatment are found. Expand
Impact of N-tau on adult hippocampal neurogenesis, anxiety, and memory
TLDR
It is found that N-tau reduced the proliferation of progenitor cells in the adult dentate gyrus, reduced cell survival and increased cell death by a caspase-3-independent mechanism, and recruited microglia, which resulted in an increase of anxiety-related behavior and an impairment of episodic-like memory. Expand
The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond.
TLDR
The vascular hypothesis of Alzheimer’s disease (AD) has become a useful concept in identifying vascular risk factors for AD or vascular dementia that can be modified to treat AD and vascular dementia. Expand
...
1
2
3
4
5
...